Protein Arginine Methyltransferase 5 (PRMT5) Signaling Suppresses Protein Kinase Cδ- and p38δ-dependent Signaling and Keratinocyte Differentiation

被引:23
|
作者
Kanade, Santosh R. [1 ]
Eckert, Richard L. [1 ,2 ,3 ,4 ]
机构
[1] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Reprod Sci, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
HUMAN INVOLUCRIN PROMOTER; HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; P38 MAP KINASE; GENE-EXPRESSION; CROSS-LINKING; PKC-DELTA; CORNIFIED ENVELOPE; P38-DELTA MAPK;
D O I
10.1074/jbc.M111.331660
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PKC delta is a key regulator of keratinocyte differentiation that activates p38 delta phosphorylation leading to increased differentiation as measured by an increased expression of the structural protein involucrin. Our previous studies suggest that p38 delta exists in association with protein partners. A major goal is to identify these partners and understand their role in regulating keratinocyte differentiation. In this study we use affinity purification and mass spectrometry to identify protein arginine methyltransferase 5 (PRMT5) as part of the p38 delta signaling complex. PRMT5 is an arginine methyltransferase that symmetrically dimethylates arginine residues on target proteins to alter target protein function. We show that PRMT5 knockdown is associated with increased p38 delta phosphorylation, suggesting that PRMT5 impacts the p38 delta signaling complex. At a functional level we show that PRMT5 inhibits the PKC delta- or 12-O-tetradecanoylphorbol- 13-acetate-dependent increase in human involucrin expression, and PRMT5 dimethylates proteins in the p38 delta complex. Moreover, PKC delta expression reduces the PRMT5 level, suggesting that PKC delta activates differentiation in part by reducing PRMT5 level. These studies indicate antagonism between the PKC delta and PRMT5 signaling in control of keratinocyte differentiation.
引用
收藏
页码:7313 / 7323
页数:11
相关论文
共 50 条
  • [31] Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A
    Sakai, Nobuya
    Saito, Yumiko
    Fujiwara, Yoko
    Shiraki, Takashi
    Imanishi, Yorihisa
    Koshimizu, Taka-aki
    Shibata, Katsushi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 778 - 784
  • [32] RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity
    Guderian, Gernot
    Peter, Christoph
    Wiesner, Julia
    Sickmann, Albert
    Schulze-Osthoff, Klaus
    Fischer, Utz
    Grimmler, Matthias
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (03) : 1976 - 1986
  • [33] Structural insights into protein arginine symmetric dimethylation by PRMT5
    Sun, Litao
    Wang, Mingzhu
    Lv, Zongyang
    Yang, Na
    Liu, Yingfang
    Bao, Shilai
    Gong, Weimin
    Xu, Rui-Ming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (51) : 20538 - 20543
  • [34] Protein Kinase C/Mitogen-Activated Protein Kinase Signaling in Keratinocyte Differentiation control
    Denning, Mitchell F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (08) : 1968 - 1970
  • [35] Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer
    Sapir, Tzuriel
    Shifteh, David
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 388 - 394
  • [36] The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription
    Fan, Zhiwen
    Kong, Xiaocen
    Xia, Jun
    Wu, Xiaoyan
    Li, He
    Xu, Huihui
    Fang, Mingming
    Xu, Yong
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (05): : 687 - 696
  • [37] Protein Arginine Methyltransferase 1 Interacts with and Activates p38α to Facilitate Erythroid Differentiation
    Hua, Wei-Kai
    Chang, Yuan-I
    Yao, Chao-Ling
    Hwang, Shiaw-Min
    Chang, Chung-Yi
    Lin, Wey-Jinq
    PLOS ONE, 2013, 8 (03):
  • [38] Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors
    Zhu, Kongkai
    Song, Jia-Li
    Tao, Hong-Rui
    Cheng, Zhi-Qiang
    Jiang, Cheng-Shi
    Zhang, Hua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (23-24) : 3693 - 3699
  • [39] Developing a first in class of drug to inhibit protein arginine methyltransferase 5 (PRMT5) enzyme dysregulation in glioblastoma multiforme.
    Yan, Fengting
    Gordon, Kate
    Mahasenan, Kiran
    Lustberg, Mark
    Alinari, Lapo
    Earl, Christian T.
    Kaur, Balveen
    Li, Chenglong
    Baiocchi, Robert A.
    CANCER RESEARCH, 2013, 73 (08)
  • [40] Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma
    Yan, Fengting
    Smith, Porsha
    Alinari, Lapo
    Ryu, John
    Yu, Bo
    Karkhanis, Vrajesh
    Tae, Sookil
    Patton, John T.
    Wilding, Emily E.
    Gordon, Kate
    Mahasenan, Kiran
    Bhasin, Deepak
    Agostinelli, Claudio
    Pileri, Stefano A.
    Byrd, John C.
    Sif, Said
    Li, Pui-kai
    Li, Chenglong
    Baiocchi, Robert A.
    BLOOD, 2011, 118 (21) : 274 - 274